New system records rise in reported adverse events
EMA Highlights – by Gary Finnegan – A new system designed to increase the safety of medicines in Europe has seen a significant increase in the number of… read more.
EMA Highlights – by Gary Finnegan – A new system designed to increase the safety of medicines in Europe has seen a significant increase in the number of… read more.
Emerging uses of FDA approved drugs – by Bruce Sylvester – Over half of depressed subjects in a newly reported study who were injected with onabotulinumtoxinA (OBA/Botox) achieved… read more.
by Bruce Sylvester – Emerging uses of FDA approved drugs – Eplerenone, a drug used to reduce the risk of death in patients with heart failure, shows significant… read more.
by Bruce Sylvester – Emerging uses of FDA approved drugs – Immunosuppresant drugs used to prevent organ rejection after transplantation could become used in fighting persistent HIV infection,… read more.
by Bruce Sylvester – Emerging uses of FDA-approved drugs – Treatment with acetazolamide plus a low-sodium weight-reduction diet for patients diagnosed with idiopathic intracranial hypertension (IIH)mand mild vision… read more.
by Bruce Sylvester – Pregnant women who take non-steroidal anti-inflammatory drugs do not increase their risk of miscarriages, researchers report in a study published on Feb. 3, 2014… read more.
Common cholesterol-lowering drugs could provide relief to patients suffering from a chronic lung disease, a study has shown. Statins were found to help alleviate the chronic coughing associated… read more.
by Gary Finnegan: The European Medicines Agency (EMA) has recommended approval of several new medicines.
by Gary Finnegan – Medicines regulators have pledged closer transatlantic cooperation on medicine safety, building on earlier commitments to join forces on clinical trial site inspections.
by Gary Finnegan – The European drug regulator has given a paediatric-use marketing authorisation (PUMA) for Hemangiol to treat proliferation of infantile haemangioma.
by Bruce Sylvester: Ongoing statin treatment appears to prevent delirium in critically ill patients who had taken a statin prior to hospitalization, researchers reported online on Jan. 17,… read more.
by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.